FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079716079> ?p ?o ?g. }

• W2079716079 endingPage "303" @default.
• W2079716079 startingPage "291" @default.
• W2079716079 abstract "Based on an analysis of their reactivity with porcine peripheral blood lymphocytes (PBL), only three of the 57 mAbs assigned to the T cell/activation marker group were grouped into cluster T9 along with the two wCD8 workshop standard mAbs 76-2-11 (CD8a) and 11/295/33 (CD8b). Their placement was verified through the use of two-color cytofluorometry which established that all three mAbs (STH101, #090; UCP1H12-2, #139; and PG164A, #051) bind exclusively to CD8+ cells. Moreover, like the CD8 standard mAbs, these three mAbs reacted with two proteins with a MW of 33 and 35 kDa from lymphocyte lysates and were, thus, given the wCD8 designation. Because the mAb STH101 inhibited the binding of mAb 76-2-11 but not of 11/295/33, it was given the wCD8a designation. The reactivity of the other two new mAbs in the T9 cluster with the various subsets of CD8+ lymphocytes were distinct from that of the other members in this cluster including the standards. Although the characteristic porcine CD8 staining pattern consisting of CD8low and CD8high cells was obtained with the mAb UCP1H12-2, a wider gap between the fluorescence intensity of the CD8low and CD8high lymphocytes was observed. In contrast, the mAb PG164A, not only exclusively reacted with CD4−/CD8high lymphocytes, but it also failed to recognize CD4/CD8 double positive lymphocytes. It was concluded that this mAb is specific for a previously unrecognized CD8 epitope, and was, thus, given the wCD8c designation. A very similar reactivity pattern to that of PG164A was observed for two other mAbs (STH106, #094; and SwNL554.1, #009). Although these two mAbs were not originally positioned in the T cell subgroup because of their reactivity and their ability to inhibit the binding of PG164A, they were given the wCD8c designation. Overall, five new wCD8 mAbs were identified. Although the molecular basis for the differences in PBL recognition by these mAbs is not yet understood, they will be important in defining the role of CD8+ lymphocyte subsets in health and disease." @default.
• W2079716079 created "2016-06-24" @default.
• W2079716079 creator A5000658746 @default.
• W2079716079 creator A5012095886 @default.
• W2079716079 creator A5013943720 @default.
• W2079716079 creator A5027376408 @default.
• W2079716079 creator A5029719511 @default.
• W2079716079 creator A5031796850 @default.
• W2079716079 creator A5038883321 @default.
• W2079716079 creator A5039088246 @default.
• W2079716079 creator A5044526137 @default.
• W2079716079 creator A5052947185 @default.
• W2079716079 creator A5059573223 @default.
• W2079716079 creator A5062691558 @default.
• W2079716079 creator A5071347032 @default.
• W2079716079 creator A5073338357 @default.
• W2079716079 creator A5075108470 @default.
• W2079716079 creator A5078143279 @default.
• W2079716079 creator A5083684557 @default.
• W2079716079 date "1998-01-01" @default.
• W2079716079 modified "2023-10-17" @default.
• W2079716079 title "Report on the analyses of mAb reactive with porcine CD8 for the second international swine CD workshop" @default.
• W2079716079 cites W1485925164 @default.
• W2079716079 cites W1512698525 @default.
• W2079716079 cites W1569350768 @default.
• W2079716079 cites W1971203081 @default.
• W2079716079 cites W1989599693 @default.
• W2079716079 cites W2008779901 @default.
• W2079716079 cites W2036287577 @default.
• W2079716079 cites W2038254677 @default.
• W2079716079 cites W2038760283 @default.
• W2079716079 cites W2045339536 @default.
• W2079716079 cites W2045939638 @default.
• W2079716079 cites W2049121617 @default.
• W2079716079 cites W2061115780 @default.
• W2079716079 cites W2066332010 @default.
• W2079716079 cites W2080036138 @default.
• W2079716079 cites W2081451533 @default.
• W2079716079 cites W2106160458 @default.
• W2079716079 cites W2128940814 @default.
• W2079716079 cites W2139987022 @default.
• W2079716079 cites W2156101125 @default.
• W2079716079 doi "https://doi.org/10.1016/s0165-2427(97)00106-2" @default.
• W2079716079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9589568" @default.
• W2079716079 hasPublicationYear "1998" @default.
• W2079716079 type Work @default.
• W2079716079 sameAs 2079716079 @default.
• W2079716079 citedByCount "38" @default.
• W2079716079 countsByYear W20797160792013 @default.
• W2079716079 countsByYear W20797160792015 @default.
• W2079716079 countsByYear W20797160792016 @default.
• W2079716079 countsByYear W20797160792018 @default.
• W2079716079 countsByYear W20797160792022 @default.
• W2079716079 crossrefType "journal-article" @default.
• W2079716079 hasAuthorship W2079716079A5000658746 @default.
• W2079716079 hasAuthorship W2079716079A5012095886 @default.
• W2079716079 hasAuthorship W2079716079A5013943720 @default.
• W2079716079 hasAuthorship W2079716079A5027376408 @default.
• W2079716079 hasAuthorship W2079716079A5029719511 @default.
• W2079716079 hasAuthorship W2079716079A5031796850 @default.
• W2079716079 hasAuthorship W2079716079A5038883321 @default.
• W2079716079 hasAuthorship W2079716079A5039088246 @default.
• W2079716079 hasAuthorship W2079716079A5044526137 @default.
• W2079716079 hasAuthorship W2079716079A5052947185 @default.
• W2079716079 hasAuthorship W2079716079A5059573223 @default.
• W2079716079 hasAuthorship W2079716079A5062691558 @default.
• W2079716079 hasAuthorship W2079716079A5071347032 @default.
• W2079716079 hasAuthorship W2079716079A5073338357 @default.
• W2079716079 hasAuthorship W2079716079A5075108470 @default.
• W2079716079 hasAuthorship W2079716079A5078143279 @default.
• W2079716079 hasAuthorship W2079716079A5083684557 @default.
• W2079716079 hasConcept C142724271 @default.
• W2079716079 hasConcept C147483822 @default.
• W2079716079 hasConcept C153911025 @default.
• W2079716079 hasConcept C159047783 @default.
• W2079716079 hasConcept C159654299 @default.
• W2079716079 hasConcept C167672396 @default.
• W2079716079 hasConcept C195616568 @default.
• W2079716079 hasConcept C203014093 @default.
• W2079716079 hasConcept C204787440 @default.
• W2079716079 hasConcept C2776910235 @default.
• W2079716079 hasConcept C2777761686 @default.
• W2079716079 hasConcept C2780218660 @default.
• W2079716079 hasConcept C2992881475 @default.
• W2079716079 hasConcept C3017910909 @default.
• W2079716079 hasConcept C3020391436 @default.
• W2079716079 hasConcept C542903549 @default.
• W2079716079 hasConcept C54355233 @default.
• W2079716079 hasConcept C71924100 @default.
• W2079716079 hasConcept C74864618 @default.
• W2079716079 hasConcept C86803240 @default.
• W2079716079 hasConceptScore W2079716079C142724271 @default.
• W2079716079 hasConceptScore W2079716079C147483822 @default.
• W2079716079 hasConceptScore W2079716079C153911025 @default.
• W2079716079 hasConceptScore W2079716079C159047783 @default.
• W2079716079 hasConceptScore W2079716079C159654299 @default.
• W2079716079 hasConceptScore W2079716079C167672396 @default.
• W2079716079 hasConceptScore W2079716079C195616568 @default.

• next